Valmet Completes Acquisition of Körber’s Business Area Tissue

Print this Article | Send to Colleague

Valmet has completed the acquisition of Körber’s Business Area Tissue, the provider of innovative process technologies and related services for converting tissue jumbo reels into final tissue products. The closing of the transaction follows the agreement that was announced on July 7, 2023.

Tissue Converting forms a business unit in the Paper business line

By combining the complementary offering and competences of Valmet and the acquired business, Valmet creates the markets’ widest technology, automation and services offering for the growing tissue industry covering the entire tissue value chain from fiber to finished products.

The new Tissue Converting business will operate as a business unit integrated in Valmet’s Paper business line. It focuses on delivering and serving converting lines for rolled and folded tissue products, packaging equipment and on providing digital solutions and services. The acquired business enables Valmet to serve the tissue industry with wider expertise, process technologies and services covering end-to-end solutions including automation systems and flow control equipment.

Pasi Laine, President and CEO of Valmet:

“Today we are happy to welcome the market leader in tissue converting and close to 1,200 new dedicated colleagues to Valmet. The acquisition is a good strategic fit and complements Valmet’s tissue making offering with strong expertise and complete solutions from tissue converting to packaging. By entering the tissue converting business, we take again a step forward with strengthened capabilities to serve our global customers even better.”

Oswaldo Cruz Junior, Head of Tissue Converting business unit, Valmet:

“Today marks the beginning of an important new chapter in our history, and we are very excited to be joining Valmet. Being part of Valmet will support the growth of our operations in the tissue converting business and allow us to boost innovative projects. Now we can be even closer to customers as a one stop shop market leader.”

Details of the transaction

The enterprise value of the acquisition is approximately EUR 380 million on a cash and debt free basis subject to ordinary post-closing adjustments. The acquisition was completed on November 2, 2023.

Valmet estimates that the acquisition will bring sales, service and cost synergies worth of EUR 8 million by the end of 2026. In Valmet’s reporting, the process technology part of the business will be consolidated to Paper business line and the services part to the Services business line.

Back to Tissue360 Newsletter